Citation Impact
Citing Papers
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
2008 StandoutScience
G Protein-coupled Receptor Kinases Phosphorylate LRP6 in the Wnt Pathway
2009 StandoutNobel
Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
2009 Standout
Effect of blockade of postsynaptic H1 or H2 receptors or activation of presynaptic H3 receptors on catecholamine-induced stimulation of ACTH and prolactin secretion
2000
An update on the mechanisms of the psychostimulant effects of caffeine
2007
Merkel Cells Activate Sensory Neural Pathways through Adrenergic Synapses
2018 StandoutNobel
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
2002 Standout
Escalation of methamphetamine self-administration in rats: a dose–effect function
2006
Dysfunction of the prefrontal cortex in addiction: neuroimaging findings and clinical implications
2011 Standout
G Protein-Coupled Receptor Kinase Function Is Essential for Chemosensation in C. elegans
2004 StandoutNobel
Comparison of the effects of the dopamine D2 agonist quinelorane on tuberoinfundibular dopaminergic neuronal activity in male and female rats
1993
The Effects of Paradoxical Sleep Deprivation and Valine on Spatial Learning and Brain 5-HT Metabolism
1999
Mechanisms Underlying Inflammation in Neurodegeneration
2010 Standout
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
2006 Standout
Melanin Pigmentation in Mammalian Skin and Its Hormonal Regulation
2004 Standout
Analysis of VMAT2 Binding After Methamphetamine or MPTP Treatment
2000
Glutamate uptake
2001 Standout
Characterization of the Dopaminergic Input to the Pituitary Gland throughout the Estrous Cycle of the Rat
1998
Melatonin attenuates methamphetamine‐induced deactivation of the mammalian target of rapamycin signaling to induce autophagy in SK‐N‐SH cells
2008
Drug Addiction and Its Underlying Neurobiological Basis: Neuroimaging Evidence for the Involvement of the Frontal Cortex
2002 Standout
Rhabdomyolysis and Acute Kidney Injury
2009 Standout
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
Monooxygenase X, a Member of the Copper-dependent Monooxygenase Family Localized to the Endoplasmic Reticulum
2004
Mechanisms of neurotransmitter release by amphetamines: A review
2005 Standout
Role of α-synuclein in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in mice
2003 StandoutNobel
Endocrine regulation of neurotransmitter transporters
1999
The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)
2003 Standout
Sexual differences in the stimulatory effects of bombesin on tuberoinfundibular dopaminergic neurons
1992
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
The NOX Family of ROS-Generating NADPH Oxidases: Physiology and Pathophysiology
2007 Standout
Food Deprivation Decreases mRNA and Activity of the Rat Dopamine Transporter
1998
β-Lactam antibiotics offer neuroprotection by increasing glutamate transporter expression
2005 StandoutNature
Low Level of Brain Dopamine D2 Receptors in Methamphetamine Abusers: Association With Metabolism in the Orbitofrontal Cortex
2001 Standout
Central nervous system control of food intake
2000 StandoutNature
Methamphetamine-induced deficits of brain monoaminergic neuronal markers: distal axotomy or neuronal plasticity
2003
Mood Disturbances and Regional Cerebral Metabolic Abnormalities inRecently Abstinent Methamphetamine Abusers
2004
Fast uptake and long-lasting binding of methamphetamine in the human brain: Comparison with cocaine
2008
Contributions of the orbitofrontal cortex to impulsive choice: interactions with basal levels of impulsivity, dopamine signalling, and reward-related cues
2010
MK-801 and dextromethorphan block microglial activation and protect against methamphetamine-induced neurotoxicity
2005
An Akt/β-Arrestin 2/PP2A Signaling Complex Mediates Dopaminergic Neurotransmission and Behavior
2005 StandoutNobel
The epidemiology of Parkinson's disease: risk factors and prevention
2016 Standout
Major Depressive Disorder
2008 Standout
Brief, repeated exposure to substrates down‐regulates dopamine transporter function in Xenopus oocytes in vitro and rat dorsal striatum in vivo
2002
Methamphetamine toxicity and messengers of death
2009
A review on emerging contaminants in wastewaters and the environment: Current knowledge, understudied areas and recommendations for future monitoring
2014 Standout
Dopamine Quinones Activate Microglia and Induce a Neurotoxic Gene Expression Profile
2006
Non-motor features of Parkinson disease
2017 Standout
Dopaminergic Supersensitivity in G Protein-Coupled Receptor Kinase 6-Deficient Mice
2003 StandoutNobel
A ‘crash’ course on psychostimulant withdrawal as a model of depression
2002
The Canonical Notch Signaling Pathway: Unfolding the Activation Mechanism
2009 Standout
Rapid regulation of the dopamine transporter: role in stimulant addiction?
2004
Dopamine in Motivational Control: Rewarding, Aversive, and Alerting
2010 Standout
Phosphorylation and Regulation of Antidepressant-sensitive Serotonin Transporters
1998
Rhabdomyolysis and drugs of abuse
2000
Neurocircuitry of Addiction
2009 Standout
Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system
2005
Selective Inhibition of Hypoxia-Inducible Factor (HIF) Prolyl-Hydroxylase 1 Mediates Neuroprotection against Normoxic Oxidative Death via HIF- and CREB-Independent Pathways
2009 StandoutNobel
Oligomerization of Dopamine Transporters Visualized in Living Cells by Fluorescence Resonance Energy Transfer Microscopy
2003
Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2
1999 StandoutScienceNobel
Deficiency of Aph1B/C-γ-secretase disturbs Nrg1 cleavage and sensorimotor gating that can be reversed with antipsychotic treatment
2008
Copper Active Sites in Biology
2014 Standout
Methamphetamine-Induced Degeneration of Dopaminergic Neurons Involves Autophagy and Upregulation of Dopamine Synthesis
2002
Role of Dopamine Transporter in Methamphetamine-Induced Neurotoxicity: Evidence from Mice Lacking the Transporter
1998
Differential Regulation of Dopamine Transporter Function and Location by Low Concentrations of Environmental Estrogens and 17β-Estradiol
2009
Mutations in theCaenorhabditis elegansSerotonin Reuptake Transporter MOD-5 Reveal Serotonin-Dependent and -Independent Activities of Fluoxetine
2001 StandoutNobel
Methamphetamine‐ and 1‐methyl‐4‐phenyl‐ 1,2,3,6‐tetrahydropyridine‐induced dopaminergic neurotoxicity in inducible nitric oxide synthase‐deficient mice
1999
Short-Term Synaptic Plasticity
2002 Standout
Synergistic dopaminergic neurotoxicity of MPTP and inflammogen lipopolysaccharide: relevance to the etiology of Parkinson's disease
2003
Mitogen-Activated Protein Kinase Regulates Dopamine Transporter Surface Expression and Dopamine Transport Capacity
2003
Increased Acute Inflammation, Leukotriene B4-Induced Chemotaxis, and Signaling in Mice Deficient for G Protein-Coupled Receptor Kinase 6
2003 StandoutNobel
Different G protein-coupled receptor kinases govern G protein and β-arrestin-mediated signaling of V2 vasopressin receptor
2005 StandoutNobel
Enhanced Rewarding Properties of Morphine, but not Cocaine, in βarrestin-2 Knock-Out Mice
2003 StandoutNobel
Hormones and Endocrine-Disrupting Chemicals: Low-Dose Effects and Nonmonotonic Dose Responses
2012 Standout
About Sleep's Role in Memory
2013 Standout
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Functional antagonism of different G protein-coupled receptor kinases for β-arrestin-mediated angiotensin II receptor signaling
2005 StandoutNobel
Peroxynitrite Inactivation of Tyrosine Hydroxylase: Mediation by Sulfhydryl Oxidation, not Tyrosine Nitration
1999
Inhibition of Macroautophagy Triggers Apoptosis
2005 Standout
Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Smoking Cessation
2010
Dehydration-Induced Renin Secretion: Involvement of Histaminergic Neurons
1998
Amphetamine, past and present – a pharmacological and clinical perspective
2013
Critical role of microglial NADPH oxidase‐derived free radicals in the in vitro MPTP model of Parkinson's disease
2003
DESENSITIZATION OF G PROTEIN–COUPLED RECEPTORS AND NEURONAL FUNCTIONS
2004 StandoutNobel
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
2018 Standout
Amphetamine-induced loss of human dopamine transporter activity: An internalization-dependent and cocaine-sensitive mechanism
2000
Regulation of Mammalian Autophagy in Physiology and Pathophysiology
2010 Standout
Physiology of Microglia
2011 Standout
Oxidative stress in neurodegeneration: cause or consequence?
2004 Standout
Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction
2009
1-(4-Methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one (Pyrovalerone) Analogues: A Promising Class of Monoamine Uptake Inhibitors
2006
Works of Annette E. Fleckenstein being referenced
Regulation of the Vesicular Monoamine Transporter-2: A Novel Mechanism for Cocaine and Other Psychostimulants
2001
Rapid and Reversible Effects of Methamphetamine on Dopamine Transporters
1997
Methylphenidate Alters Vesicular Monoamine Transport and Prevents Methamphetamine-Induced Dopaminergic Deficits
2003
Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain
1998
Effects of histamine on 5-hydroxytryptaminergic neuronal activity in the rat hypothalamus
1994
Mechanisms of methamphetamine-induced dopaminergic neurotoxicity
2006
Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine
2002
Methamphetamine‐Induced Rapid and Reversible Reduction in the Activities of Tryptophan Hydroxylase and Dopamine Transporters: Oxidative Consequences?a
1998
Oxygen radicals diminish dopamine transporter function in rat striatum
1997
Psychostimulants and Vesicle Trafficking: A Novel Mechanism and Therapeutic Implications
2004
Oxygen radicals differentially affect Na+/Cl−-dependent transporters
1999
Differential Regional Effects of Methamphetamine on the Activities of Tryptophan and Tyrosine Hydroxylase
1999
3,4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function
1998
Age-Dependent Methamphetamine-Induced Alterations in Vesicular Monoamine Transporter-2 Function: Implications for Neurotoxicity
2005
Methamphetamine‐induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment
2007
Evidence that histamine-stimulated prolactin secretion is not mediated by an inhibition of tuberoinfundibular dopaminergic neurons
1992
Differential role of histamine in mediating stress-induced changes in central dopaminergic neuronal activity in the rat
1994
Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors
2003
A Single Methamphetamine Administration Rapidly Decreases Vesicular Dopamine Uptake
2002
Methylenedioxymethamphetamine Decreases Plasmalemmal and Vesicular Dopamine Transport: Mechanisms and Implications for Neurotoxicity
2002
Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications
2008
Persistence of tolerance to methamphetamine-induced monoamine deficits
2006
Differential effects of stimulants on monoaminergic transporters: Pharmacological consequences and implications for neurotoxicity
2000
Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism
2004
The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity
2003
Histaminergic neurons mediate restraint stress-induced activation of central 5-hydroxyrytaminergic neurons in the rat
1994
Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function
1999
Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters
1998
Impact of psychostimulants on vesicular monoamine transporter function
2003
Bupropion increases striatal vesicular monoamine transport
2005
Evidence That Prolactin Mediates the Stimulatory Effects of Estrogen on Tuberoinfundibular Dopamine Neurons in Female Rats
1992
Alterations in Vesicular Dopamine Uptake Contribute to Tolerance to the Neurotoxic Effects of Methamphetamine
2004
Inhibitory effect of reserpine on dopamine transporter function
2002
Age‐Dependent Effects of Methamphetamine on VMAT‐2
2006
A rapid and reversible change in dopamine transporters induced by methamphetamine
1997
Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: A population-based assessment
2014
Methamphetamine Rapidly Decreases Vesicular Dopamine Uptake
2000
Methamphetamine-Induced Rapid and Reversible Changes in Dopamine Transporter Function: AnIn VitroModel
2001
Interaction Between Hyperthermia and Oxygen Radical Formation in the 5-Hydroxytryptaminergic Response to a Single Methamphetamine Administration
1997
New Insights into the Mechanism of Action of Amphetamines
2007
Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].
1996
Methamphetamine-Induced Rapid Decrease in Dopamine Transporter Function: Role of Dopamine and Hyperthermia
2000
Methamphetamine-induced rapid and reversible changes in dopamine transporter function: an in vitro model.
2001